title: Reply to Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response-Directed High-Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).
authors.affiliation: Clinical Oncology, University of Oxford, Oxford, UK.
authors.forename: Sindu
authors.initials: S
authors.lastname: Vivekanandan
authors.affiliation: Paediatric Oncology, Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital, Cambridge, UK.
authors.forename: R
authors.initials: R
authors.lastname: Breene
authors.affiliation: Paediatric Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
authors.forename: R
authors.initials: R
authors.lastname: Ramanujachar
authors.affiliation: Paediatric Oncology, Children's Hospital for Wales, Cardiff, UK.
authors.forename: H
authors.initials: H
authors.lastname: Traunecker
authors.affiliation: Paediatric Oncology, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, UK.
authors.forename: B
authors.initials: B
authors.lastname: Pizer
authors.affiliation: Clinical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.
authors.forename: M N
authors.initials: MN
authors.lastname: Gaze
authors.affiliation: Clinical Oncology, The Royal Marsden NHS Foundation Trust, Surrey, UK.
authors.forename: F
authors.initials: F
authors.lastname: Saran
authors.affiliation: Clinical Oncology, The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK.
authors.forename: N
authors.initials: N
authors.lastname: Thorp
authors.affiliation: Paediatric Oncology, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK.
authors.forename: M
authors.initials: M
authors.lastname: English
authors.affiliation: Paediatric Oncology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
authors.forename: K
authors.initials: K
authors.lastname: Wheeler
authors.affiliation: Paediatric Oncology, Great Ormond Street Hospital For Children NHS Foundation Trust, London, UK.
authors.forename: A
authors.initials: A
authors.lastname: Michalski
authors.affiliation: Paediatric Oncology, Nottingham Children's Hospital University of Nottingham, Nottingham, UK.
authors.forename: D A
authors.initials: DA
authors.lastname: Walker
authors.affiliation: Clinical Oncology, Nottingham University Hospitals NHS Trust, Nottingham, UK.
authors.forename: D
authors.initials: D
authors.lastname: Saunders
authors.affiliation: Clinical Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK.
authors.forename: F
authors.initials: F
authors.lastname: Cowie
authors.affiliation: Clinical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
authors.forename: A
authors.initials: A
authors.lastname: Cameron
authors.affiliation: Paediatric Oncology, The Leeds Teaching Hospitals, Leeds, UK.
authors.forename: S
authors.initials: S
authors.lastname: Picton
authors.affiliation: Cancer Research Unit, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
authors.forename: D
authors.initials: D
authors.lastname: Parashar
authors.affiliation: Clinical Oncology, Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital, Cambridge, UK.
authors.forename: G
authors.initials: G
authors.lastname: Horan
authors.affiliation: Clinical Oncology, Cambridge University Hospitals NHS Foundation Trust Addenbrooke's Hospital, Cambridge, UK.
authors.forename: M V
authors.initials: MV
authors.lastname: Williams
mesh_terms: D002528:Cerebellar Neoplasms / Q000401:mortality* / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000401:mortality* / Q000628:therapy*